Jul 12, 2017 · 29m · 20vc
20VC: The Blurring of Early & Late Stage, Why Your Go To Market Strategy Is More Important Now Than Ever & Why Venture Is The Academia Of Tech with Roseanne Wincek @ IVP
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of The 20 Minute VC, host Harry Stebbings interviews Roseanne Wincek of IVP to explore her path from academia to venture capital, the blurring boundaries between early and late-stage investing, go-to-market strategies, and winning competitive growth rounds.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Harry holds 27.8% of the talking time here. How this is scored →
speaking balance: gold is Harry, purple is the guest (3 minute bins)
Roseanne gently pushes back on Harry's binary framing of early stage as art and late stage as science, pointing out that both require significant elements of both.
Hardest push from Harry ▶ 8:37 Harry proposes strict binary segregationHarry pushes Roseanne with a sharp thesis asking whether early-stage investing is an art while late-stage investing is purely a science.
Biggest teaching moment ▶ 7:50 Roseanne explains late-stage investor risk profilesRoseanne educates Harry on how late-stage VCs evaluate risk and asset pricing differently than early-stage VCs who build models around expecting one-third of companies to go to zero.
Harry holds his own ▶ 18:10 Harry synthesizes Jeremy Levine's distribution thesisHarry demonstrates deep domain preparation by invoking Jeremy Levine's thesis on platform incumbency and distribution control to test Roseanne's perspective on consumer investing.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Harry as informed peer | Guest teaching | Guest disagreement | Harry pushing back | Why |
|---|---|---|---|---|---|---|
| Roseanne Wincek's Path from Academia to Venture Capital | 2 | 4 | 0 | 1 | Harry asks a broad opening question about Roseanne's path into venture capital, prompting a long monologue about her journey from biophysics academia to early-stage founder and growth investor. Harry mostly listens attentively, offering a brief summarizing phrase midway through. | |
| Comparing Early-Stage and Late-Stage Venture Dynamics | 3 | 5 | 2 | 4 | Harry tries to synthesize the differences between early and late stage by asking if early-stage is an art and late-stage is a science. Roseanne gently reframes his question, explaining that both stages involve a mix of art and science. | |
| Follow-On Strategy and the Blurring of VC Stages | 4 | 4 | 1 | 2 | Harry demonstrates strong industry knowledge by bringing up fund size shifts, LP co-investments, and mega-funds like NEA. Roseanne details how prorata calculations and fund mechanics differ between early and late-stage investors. | |
| Go-To-Market Execution, Product-Market Fit, and Distribution Channels | 7 | 3 | 1 | 3 | Harry displays extensive preparation by introducing quotes and frameworks from Tom Tunguz, Jason Lemkin, Peter Fenton, and Jeremy Levine. Roseanne engages deeply with these prompts, elaborating on metrics, organic channels, and platform incumbency. | |
| Winning Competitive Deals Pre-Process | 3 | 2 | 0 | 1 | The conversation shifts to deal dynamics and quickfire topics, including questions crowdsourced from Jenny Lefcourt and Layla Sturdy. Roseanne shares her strategy for winning competitive deals before a formal process begins and discusses her investment in Masterclass. |